Insider Transactions in Q3 2021 at Clearside Biomedical, Inc. (CLSD)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2021
|
Charles A. Deignan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,800
-0.88%
|
$16,800
$6.41 P/Share
|
|
Sep 21
2021
|
George M Lasezkay CEO |
SELL
Open market or private sale
|
Direct |
3,525
-0.83%
|
$21,150
$6.46 P/Share
|
|
Sep 21
2021
|
Thomas Ciulla Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,560
-0.99%
|
$15,360
$6.4 P/Share
|
|
Sep 01
2021
|
Bradford T Whitmore > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
213,203
-8.11%
|
$1,279,218
$6.89 P/Share
|
|
Aug 31
2021
|
Bradford T Whitmore > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
107,682
-3.94%
|
$646,092
$6.96 P/Share
|
|
Aug 30
2021
|
Bradford T Whitmore > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
99,400
-3.51%
|
$695,800
$7.06 P/Share
|
|
Aug 16
2021
|
Nancy J Hutson |
BUY
Open market or private purchase
|
Direct |
3,000
+18.75%
|
$15,000
$5.68 P/Share
|